89 FR 51134
EPA proposed to address the unreasonable risk of injury to human health presented by n-methylpyrrolidone (NMP) under its conditions of use as documented in the Agency's risk evaluation and risk determination for NMP pursuant to TSCA.
Search Results
Use the filters on the left-hand side of this screen to refine the results further by topic or document type.